释放瘤免疫微环境的腺素受体机制
Yecheng Han1, Chenshuang Dong2, Mingwang Hu2
1General Affairs Office of Shenyang Hongqiao Hospital of Traditional Chinese Medicine, Shenyang, China.
Frontiers in immunology
|July 12, 2024
概括
瘤微环境通过增加免疫抑制细胞来抑制免疫疗法. 氨酸受体,特别是A2A和A2B,驱动这种抑制,突出癌症治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤微环境 (TME) 通常会抑制抗瘤免疫力,限制免疫疗法的有效性.
- 在TME内部的干细胞有助于免疫抑制,部分是通过增加免疫抑制细胞.
- 氨酸在TME中升高,通过氨酸受体促进瘤生长和免疫抑制.
研究的目的:
- 审查不同瘤微环境中各种腺受体的作用.
- 专注于 stromal 和非细胞 TME 组件中的腺素受体功能.
- 总结在将腺受体对抗剂与免疫治疗相结合方面的进展和趋势.
主要方法:
- 关于固体瘤中的腺素受体研究的文献综述.
- 分析树突细胞和非细胞TME组件中的腺素受体作用.
- 对腺受体抗剂和免疫疗法组合的当前研究的综合.
主要成果:
- 氨酸A2A和A2B受体是TME中免疫抑制的关键驱动因素.
- 树突细胞中的腺素受体信号传递显著影响免疫场景.
- 在TME中氨酸水平升高会产生一种促瘤和免疫抑制的环境.
结论:
- 向腺受体是一个有希望的策略,以克服TME介导的免疫抑制.
- 涉及腺受体抗剂和免疫疗法的组合疗法可能会提高固体瘤的治疗疗效.
- 对腺受体调节的进一步研究对于推进癌症免疫治疗至关重要.
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K


